The Single Cell Spatial Proteomics Company
Location: Sweden
Total raised: $37.5M
Investors 1
| Date | Name | Website |
| - | Navigare V... | navigareve... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.08.2026 | Series B | $15.5M | Industrifo... |
| 01.07.2025 | - | $14.7M | - |
| 09.10.2023 | Series A | $7.3M | - |
Mentions in press and media 11
| Date | Title | Description |
| 21.08.2026 | Pixelgen Technologies Raises $15.5 Million Series B To Scale Molecular Cell Architecture Platform Globally | Pixelgen Technologies has closed an oversubscribed $15.5 million Series B financing to accelerate global commercialization of its Proxiome Kit and expand the company’s presence in key markets. Flat Capital led the round, with existing inves... |
| 21.04.2026 | Lightcast Secures Major Funding, Redefines Single-Cell Analysis with Envisia Platform | Lightcast, a life science innovator, secured $27 million in funding. ARCH Venture Partners led the round. This capital fuels the 2026 commercial launch of its Envisia™ benchtop platform. Envisia marks a significant leap in single-cell analy... |
| 14.04.2026 | Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform | · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – April 14, 2026 – Lightcast, a pioneering life... |
| 01.07.2025 | Pixelgen Technologies Receives $14.7M in Funding from European Innovation Council Accelerator | Pixelgen Technologies, a Stockholm, Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue, received a grant and equity financing of $14.7M from the European Innovation Council (EIC) Accelerator. Th... |
| 29.05.2025 | ProteomEdge Secures 7.8 million SEK in Funding to Accelerate Commercialization and Appoints New CEO | This investment fuels our mission to deliver a cutting-edge analytical platform for absolute protein quantification using mass spectrometry. Our growing portfolio of proprietary products, targeting a large set of clinically relevant plasma ... |
| 21.01.2025 | New study paves way for immunotherapies tailored for childhood cancers | New study paves way for immunotherapies tailored for childhood cancers Tue, Jan 21, 2025 11:47 CET Report this content Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s... |
| 18.09.2024 | Navigare Ventures completes SweGaN equity raise of nearly 12M Euro | Linköping, Sweden, September 18, 2024: SweGaN AB, an European semiconductor manufacturer that develops and produces customengineered Gallium Nitride on Silicon Carbide (GaN-on-SiC) epitaxial wafers, announces the closing of a substantial eq... |
| 13.10.2023 | Pixelgen Technologies closes series A financing to support commercial expansion of groundbreaking spatial proteomics tools for single cells | Pixelgen Technologies, a leader in spatial proteomics for single cells, announced today that it has closed a Series A financing of approximately $7.3 million. The round was led by new investor Industrifonden, Sweden’s venture capital fund, ... |
| 09.10.2023 | Pixelgen Technologies Closes $7.3M Series A Financing | Pixelgen Technologies, a Stockholm, Sweden-based company which specializes in spatial proteomics for single cells, raised approximately $7.3M in Series A funding. The round was led by Industrifonden and Navigare Ventures. The company intend... |
| 03.02.2023 | Pixelgen Technologies Unveils Molecular Pixelation for Spatial Analysis of Cell Surface Proteins at AGBT General Meeting | STOCKHOLM, Feb. 3, 2023 /PRNewswire/ -- Pixelgen Technologies, the single cell spatial proteomics company, announced today that it will unveil its groundbreaking Molecular Pixelation technology for spatial analysis of cell surface proteins ... |
Show more